↓ Skip to main content

WOMAC Meaningful Within-Patient Change: Results from Three Studies of Tanezumab in Patients with Moderate-To-Severe Osteoarthritis of the Hip or Knee

Overview of attention for article published in Journal of Rheumatology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
3 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
WOMAC Meaningful Within-Patient Change: Results from Three Studies of Tanezumab in Patients with Moderate-To-Severe Osteoarthritis of the Hip or Knee
Published in
Journal of Rheumatology, March 2022
DOI 10.3899/jrheum.210543
Pubmed ID
Authors

Philip G Conaghan, Robert H Dworkin, Thomas J Schnitzer, Francis Berenbaum, Andrew G Bushmakin, Joseph C Cappelleri, Lars Viktrup, Lucy Abraham

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 13%
Researcher 2 13%
Student > Ph. D. Student 1 7%
Unknown 10 67%
Readers by discipline Count As %
Medicine and Dentistry 2 13%
Social Sciences 1 7%
Neuroscience 1 7%
Engineering 1 7%
Unknown 10 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2023.
All research outputs
#2,299,149
of 25,392,582 outputs
Outputs from Journal of Rheumatology
#329
of 3,951 outputs
Outputs of similar age
#54,822
of 449,877 outputs
Outputs of similar age from Journal of Rheumatology
#7
of 79 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,951 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,877 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.